Newstral
Article
bizjournals.com on 2020-08-04 16:19
German biotech MorphoSys plans growth in Boston after first drug approval
Related news
- German biotech company MorphoSys buys US rival for $1.7Bdailyherald.com
- BMorphoSys Buys Constellation Pharma in $1.7B Deal. Is Biotech M&A Back?barrons.com
- BioNTech Sparks Investments in German Biotechwsj.com
- FGerman biotech smashes European fundraising recordft.com
- After acquiring local oncology firm, MorphoSys plans to grow in Bostonbizjournals.com
- Ford wins approval for German banking licencetimesofmalta.com
- German spying law approval prompts protestPressTV
- German government approval drops ahead of EasterDeutsche Welle Englisch
- Merkel urges German approval for Greek bailoutchronicle.northcoastnow.com
- German economy returns to growthtimesofmalta.com
- German economy shows 0.7% growthShropshire Star
- German Growth Accelerates in 2014wsj.com
- FGerman GDP growth beats estimatesft.com
- German economy sees strong growthBBC
- Slowdown in German economic growthBBC
- Bundesbank Sees Continued German Growthwsj.com
- German biotech company Gilupi acquired by Chinese investor Viroadtech.eu
- Gilead Sciences acquires German biotech company for $1.39 billionbizjournals.com